Date
August 2025 formulary update - effective August 14, 2025
Included in the update:
- New atomoxetine (STRATTERA) oral tablets: Previously formulary restricted
- New indomethacin (INDOCID) suppositories: Previously discontinued from market
- New lisdexamfetamine (VYVANSE) oral capsules: Previously formulary restricted
- New formulary restricted medications from BC Cancer
- Several medication updates
- Several discontinued medications
For more information, please contact:
Jessica Granberg, Medication Use Management Pharmacists
mumpharmacist@northernhealth.ca